Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2018 Q4
18 of 25 quarters
Total Value
$293.0K
Total Shares
20.0K
Net Share Change
-150.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Miller Value Partners
$293.0K
20.0K
0.0%
TRIM
-150.0K
(-88.2%)
Miller Value Partners
$293.0K
20.0K shares
TRIM
-150.0K
(-88.2%)
HALO — Halozyme Therapeutics Inc - FilingSpy